Utility of plasmatic levels of alpha-1-antiprotease (A1AP) as a cancer marker
- 10 February 1995
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 89 (1) , 15-21
- https://doi.org/10.1016/0304-3835(95)90152-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Peri- and postoperative changes in serum levels of four tumor markers and three acute phase reactants in benign and malignant gynecological diseasesArchiv für Gynäkologie, 1992
- Lack of increase in heterozygous α1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinomaHepatology, 1992
- Acute phase reactant proteins—an aid to monitoring surgical treatment of laryngeal carcinomaThe Journal of Laryngology & Otology, 1992
- Statistics with Confidence: Confidence Intervals and Statistical Guidelines.Journal of the Royal Statistical Society Series A: Statistics in Society, 1990
- A REAPPRAISAL OF RHEUMATIC DISEASES AND IMMUNOGENETICSThe Lancet, 1984
- Serum proteinase-like peptidase activities and proteinase inhibitors in women with breast diseaseEuropean Journal of Cancer and Clinical Oncology, 1984
- Changes in acute phase reactants and disturbances in metabolism after burn injuryBurns, 1983
- Structure and variation of human α1–antitrypsinNature, 1982
- Interaction of chymotrypsinogens with .alpha.1-protease inhibitorBiochemistry, 1980
- The interaction of α-1-antitrypsin with chymotrypsin, trypsin and elastaseBiochimica et Biophysica Acta (BBA) - Enzymology, 1975